1. Home
  2. LEXX vs GVH Comparison

LEXX vs GVH Comparison

Compare LEXX & GVH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LEXX
  • GVH
  • Stock Information
  • Founded
  • LEXX 2004
  • GVH 2016
  • Country
  • LEXX Canada
  • GVH Australia
  • Employees
  • LEXX N/A
  • GVH N/A
  • Industry
  • LEXX Biotechnology: Pharmaceutical Preparations
  • GVH
  • Sector
  • LEXX Health Care
  • GVH
  • Exchange
  • LEXX Nasdaq
  • GVH Nasdaq
  • Market Cap
  • LEXX 19.6M
  • GVH 21.3M
  • IPO Year
  • LEXX N/A
  • GVH 2023
  • Fundamental
  • Price
  • LEXX $0.83
  • GVH $0.13
  • Analyst Decision
  • LEXX Strong Buy
  • GVH
  • Analyst Count
  • LEXX 1
  • GVH 0
  • Target Price
  • LEXX $7.00
  • GVH N/A
  • AVG Volume (30 Days)
  • LEXX 146.6K
  • GVH 47.8M
  • Earning Date
  • LEXX 07-11-2025
  • GVH 02-12-2025
  • Dividend Yield
  • LEXX N/A
  • GVH N/A
  • EPS Growth
  • LEXX N/A
  • GVH 12.04
  • EPS
  • LEXX N/A
  • GVH 0.09
  • Revenue
  • LEXX $525,923.00
  • GVH $16,540,178.00
  • Revenue This Year
  • LEXX $0.62
  • GVH N/A
  • Revenue Next Year
  • LEXX $14.19
  • GVH N/A
  • P/E Ratio
  • LEXX N/A
  • GVH $1.45
  • Revenue Growth
  • LEXX 29.95
  • GVH N/A
  • 52 Week Low
  • LEXX $0.82
  • GVH $0.11
  • 52 Week High
  • LEXX $4.38
  • GVH $1.82
  • Technical
  • Relative Strength Index (RSI)
  • LEXX 31.77
  • GVH 22.26
  • Support Level
  • LEXX $0.93
  • GVH $1.33
  • Resistance Level
  • LEXX $1.05
  • GVH $1.54
  • Average True Range (ATR)
  • LEXX 0.07
  • GVH 0.14
  • MACD
  • LEXX -0.00
  • GVH -0.14
  • Stochastic Oscillator
  • LEXX 14.14
  • GVH 0.99

About LEXX Lexaria Bioscience Corp.

Lexaria Bioscience Corp's patented drug delivery technology, DehydraTECH improves the way active pharmaceutical ingredients enter the bloodstream by promoting more effective oral delivery. DehydraTECH can increase bio-absorption with cannabinoids and nicotine by 5-10x and, in some instances with cannabinoids by as much as 27x compared to standard industry formulations, reduce the time of onset from 1-2 hours to minutes, and mask unwanted tastes. DehydraTECH has also evidenced an ability to deliver some drugs more effectively across the blood-brain barrier. The company has four reportable segments: Intellectual Property Licensing which generates maximum revenue, B2B Production, Research and Development, and Corporate. Geographically, it derives revenue from the United States and Canada.

About GVH Globavend Holdings Limited

Globavend Holdings Ltd is an e-commerce logistics provider, it provides integrated cross-border logistics services from Hong Kong to Australia and New Zealand, where it provides customers with a one-stop solution from parcel consolidation to air freight forwarding, customs clearance, on-carriage parcel transportation and delivery. It operates in logistics and freight forwarding industry, which involves the provision of services such as freight transport, freight forwarding, warehouse management, and distribution.

Share on Social Networks: